50 Participants Needed

Balloon Sinusotomy for Sinusitis

SS
DM
Overseen ByDennis M Tang, MD
Age: 18+
Sex: Any
Trial Phase: Phase 2 & 3
Sponsor: Cedars-Sinai Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to evaluate the effectiveness of a procedure called maxillary balloon sinusotomy for individuals with chronic maxillary rhinosinusitis, a condition causing persistent sinus problems. The procedure uses navigation tools, making it less invasive than traditional surgery. Suitable candidates have ongoing sinus issues that have not improved with other treatments and are considering sinus surgery for the first time. As a Phase 2, Phase 3 trial, this research assesses the procedure's effectiveness in a smaller group and represents the final step before FDA approval, offering participants an opportunity to contribute to the development of an innovative treatment.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.

What prior data suggests that maxillary balloon sinusotomy is safe for treating chronic maxillary rhinosinusitis?

Research has shown that using a balloon to open the sinuses is generally safe for treating long-term sinus problems. In a study with 115 patients, the procedure proved safe over a 24-week period. Another study found that using a sinus balloon can help reduce complications in people with chronic sinus issues. Additionally, long-term results suggest that this treatment is both safe and effective.

Overall, these studies indicate that the procedure is well-tolerated, with few serious side effects reported. Most people who undergo the procedure do not experience major problems. For those considering joining a trial for this treatment, existing research offers reassurance about its safety.12345

Why do researchers think this study treatment might be promising?

Balloon Sinusotomy for sinusitis is unique because it offers a minimally invasive alternative to traditional sinus surgery. Unlike conventional treatments that may involve cutting tissue to clear sinus blockages, this technique uses a small balloon to gently dilate the sinus passages, which can reduce pain and recovery time. Researchers are excited about this method because it has the potential to be safer and more comfortable for patients, with quicker recovery and fewer complications compared to the standard endoscopic sinus surgery.

What evidence suggests that maxillary balloon sinusotomy is effective for chronic maxillary rhinosinusitis?

Studies have shown that maxillary balloon sinusotomy, a type of balloon sinuplasty, effectively treats long-term sinus infections in the cheek area. Research indicates that this procedure is safe and can provide lasting relief for patients. Some studies found that only a small number of patients required additional sinus surgery afterward, suggesting successful initial results. Overall, the procedure reduces complications and offers a promising solution for those with chronic sinus problems.12367

Are You a Good Fit for This Trial?

This trial is for adults over 18 who have chronic sinusitis in the maxillary sinuses and haven't improved with medication. They should be candidates for their first sinus surgery but can't have nasal polyps.

Inclusion Criteria

My condition did not improve with medication.
I am a candidate for sinus surgery due to chronic sinusitis without nasal polyps.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo maxillary balloon sinusotomy with or without navigation

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the procedure

4 weeks
1-2 visits (in-person)

Long-term follow-up

Participants are monitored for long-term outcomes and success rate

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Maxillary Balloon Sinusotomy
Trial Overview The study is testing how well a navigation system helps doctors when they use a balloon to open up the sinuses in patients with chronic maxillary sinusitis.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cedars-Sinai Medical Center

Lead Sponsor

Trials
523
Recruited
165,000+

Published Research Related to This Trial

The balloon dilatation technique using a Foley catheter for treating intramaxillary lesions in chronic maxillary sinusitis was found to be minimally invasive and effective, with no significant intraoperative or postoperative complications reported in a study of 34 patients.
Postoperative outcomes, including symptom relief and lesion resolution, were comparable to those achieved with traditional functional endoscopic sinus surgery, suggesting this method is a viable alternative.
A balloon dilatation technique for the treatment of intramaxillary lesions using a Foley catheter in chronic maxillary sinusitis.Park, CH., Kim, HS., Lee, JH., et al.[2012]
A retrospective analysis of adverse events related to balloon dilation of paranasal sinus ostia identified 114 incidents, with the most common being patient injuries (72 cases), particularly orbital complications and skull base injuries.
While adverse events are relatively uncommon given the number of procedures performed, some can be severe, highlighting the importance for surgeons to be aware of specific complications associated with different sinus surgeries.
An Analysis of Adverse Event Reporting in Balloon Sinus Procedures.Prince, A., Bhattacharyya, N.[2016]
A retrospective analysis of the FDA's MAUDE database from 2008 to 2018 identified 211 adverse events related to balloon sinuplasty, with the most common complications being device malfunctions and patient-related issues like cerebrospinal fluid leaks and eye swelling.
The study highlighted that balloon and guide catheter malfunctions were the leading device-related complications, while significant eye swelling occurred frequently during procedures involving the maxillary sinus, emphasizing the need for healthcare providers to inform patients about these risks.
Adverse Events Associated with Balloon Sinuplasty: A MAUDE Database Analysis.Hur, K., Ge, M., Kim, J., et al.[2020]

Citations

Efficacy & Outcomes of Balloon Sinuplasty in Chronic ...The average surgery time was 73 min. Of the 1,036 patients treated, 25 patients (2.4%) required revision of sinuses [11]. In our study the mean average ...
Long term outcomes of balloon sinuplasty for the treatment ...Conclusion. Balloon sinuplasty appears to be safe and effective for the treatment of CRS with great long-term outcomes.
Efficacy and safety of sinus balloon catheter dilation versus ...The results indicated that SBCD was an effective intervention for CRS, capable of substantially decreasing the occurrence of complications.
Long-Term Follow-Up After Maxillary Sinus Balloon ...In this study, the revision numbers of specific sinuses were reported and the revision rate after maxillary sinus operation was 4.3%. Our ESS ...
Efficacy and safety of sinus balloon catheter dilation versus ...The results indicated that SBCD was an effective intervention for CRS, capable of substantially decreasing the occurrence of complications.
Balloon Sinuplasty: Our Experience - PMCBalloon sinuplasty is an excellent procedure which is safe and highly effective for medically nonresponsive CRS without polyposis. The success ...
CG-SURG-73 Balloon Sinus Ostial DilationThe main outcome measured was resolution of frontal sinus disease as shown by CT scan at 12 months. The authors reported that 80.76% of the operative balloon ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security